We are excited to announce a significant addition to our MyoPax team as we warmly welcome Dr. Diane Seimetz as our newest co-founder!
Diane joins the MyoPax team with an impressive background in building successful cell and gene therapy products, navigating regulatory compliance, in management and fostering industry partnerships. Her strategic insights and extensive network will play a crucial role in in propelling our biotech towards next fundamental milestones.
We warmly welcome Diane as she embarks on our mission to develop first-time effective therapies for muscle disorders and make a lasting impact on patients‘ lives.
The road ahead holds remarkable opportunities, and together, we will work tirelessly to bring breakthrough innovation to the clinic.